Additionally, osteopontin (OPN), which was previously reported to positively regulate sphere forming ability of cancer cells, was found to increase the levels of CD44, CD133, ALDH1 and LC3-II in various pancreatic cell lines, an effect that can be reversed by attenuating osteopontin activity or blocking autophagy altogether. The gene discussed is PROM1; the disease is cancer.